Nuveen Asset Management, LLC Dyadic International Inc Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.35 - $5.67 $222,332 - $376,306	-66,368 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.75 - $6.87 $23,522 - $34,020	-4,952 Reduced 6.94%	66,368 $364,000
Q4 2020 Feb 16, 2021	BUY	$5.35 - $7.77 $16,488 - $23,947	3,082 Added 4.52%	71,320 $384,000
Q3 2020 Nov 16, 2020	SELL	$7.22 - $9.11 $163,951 - $206,869	-22,708 Reduced 24.97%	68,238 $516,000
Q2 2020 Aug 14, 2020	BUY	$4.93 - $10.26 $448,363 - $933,105	90,946 New	90,946 $788,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $49.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.